March 9, 2006 (San Francisco) — The largest and arguably most complex risk-management program ever undertaken by the US Food and Drug Administration is sparking a commensurate measure of controversy — ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback